Immunogenetics of Cytokines: Relevance for Future Research on Inflammatory Bowel Disease

References

• Mølvig J, Baek L, Christensen P, Manogue K R, Vlassara H, Platz P, et al. Endotoxin-stimulated human monocyte secretion of interleukin-1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1988; 27: 705–16
   PubMed Web of Science ®Google Scholar
• Endres S, Cannon J G, Ghorbani R, Dempsey R A, Sisson S D, Lonnemann G, et al. In vitro production of IL-l alpha, IL-1beta, TNF and IL-2 in healthy subjects: distribution, effect of cyclo-oxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989; 19: 2327–33
   PubMed Web of Science ®Google Scholar
• Penˆa A S, Crusius J BA, Oudkerk Pool M, Cracia Casanova M, Pals G, Meuwissen S GM, et al. Genetics and epidemiology may contribute to understanding the pathogenesis of IBD—a new approach is now indicated. Can J Gastroenterol 1993; 7: 71–5
   Google Scholar
• Koutroubakis I, Penˆa AS. Genetics of inflammatory bowel disease. Inflammatory bowel disease.3rd ed., R N Allan, M RB Keighley, J Rhodes, J Alexander-Williams, C Hawkins. Churchill Livingstone, London 1995, In press
   Google Scholar
• Brynskov J, Nielsen O H, Ahnfeltronne I, Bendtzen K. Cytokines in inflammatory bowel disease [review]. Scand J Gastroenterol 1992; 27: 897–906
   PubMed Web of Science ®Google Scholar
• Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533–9
   PubMed Web of Science ®Google Scholar
• Fiocchi C. Cytokines. Inflammatory bowel disease. From bench to bedside, S R Targan, F Shanahan. Williams & Wilkins, Baltimore 1994; 106–22
   Google Scholar
• Radford-Smith G, Jewell DP. The role of cytokines in inflammatory bowel disease. Mediators Inflam 1994; 3: 3–9
   PubMed Web of Science ®Google Scholar
• Mullin G E, Lazenby A J, Harris M L, Bayless T M, James SP. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992; 102: 1620–7
   PubMed Web of Science ®Google Scholar
• Breese E, Braegger C P, Corrigan C J, Walker-Smith J A, MacDonald IT. Interleukin-2- and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78: 127–31
   PubMed Web of Science ®Google Scholar
• Mullin G E, Vezza F R, Sampat A, Mayson Z, Kalz R, Eisenstein E, et al. Abnormal IL-10 mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 1993; 104: A751
   Web of Science ®Google Scholar
• Cominelli F, Nast C C, Clark B D, Schindler R, Llerena R, Eysselein V E, et al. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990; 86: 972–80
   PubMed Web of Science ®Google Scholar
• Ligumsky M, Simon P L, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990; 31: 686–9
   PubMed Web of Science ®Google Scholar
• Mahida Y R, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989; 30: 835–8
   PubMed Web of Science ®Google Scholar
• Youngman K R, Simon P L, West G A, Cominelli F, Rachmilewitz D, Klein J S, et al. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993; 104: 749–58
   PubMed Web of Science ®Google Scholar
• Cappello M, Keshav S, Prince C, Jewell D P, Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992; 33: 1214–9
   PubMed Web of Science ®Google Scholar
• Cominelli F, Nast C C, Duchini A, Be M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992; 103: 65–71
   PubMed Web of Science ®Google Scholar
• Isaacs K L, Sartor R B, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587–95
   PubMed Web of Science ®Google Scholar
• Hyams J S, Fitzgerald J E, Wyzga N, Treem W R, Justinich C J, Kreutzer DL. Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease. Dig Dis Sci 1994; 39: 1893–9
   PubMed Web of Science ®Google Scholar
• Nicklin M J, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994; 19: 382–4
   PubMed Web of Science ®Google Scholar
• McDowell T L, Symons J A, Ploski R, Førre Ø, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-l a polymorphism. Arthritis Rheum 1995; 38: 221–8
   PubMed Web of Science ®Google Scholar
• di Giovine F S, Takhsh E, Blakemore A I, Duff GW. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1: 450
   PubMedGoogle Scholar
• van der Velden P A, Reitsma PH. Amino acid dimorphism in ILIA is detectable by PCR amplification. Hum Mol Genet 1993; 2: 1753
   Web of Science ®Google Scholar
• Epplen C, Frank G, Gomolka M, Albert E, Nurnberg P, Epplen JT. Dinucleotide repeat polymorphism in the human ILIA gene. Hum Mol Genet 1994; 3: 1710
   PubMedGoogle Scholar
• Bailly S, di Giovine F S, Blakemore A I, Duff GW. Genetic polymorphism of human interleukin-1 alpha. Eur J Immunol 1993; 23: 1240–5
   PubMed Web of Science ®Google Scholar
• di Giovine F S, Crane A, Gough A, de Vries N, Emery P, Duff GW. An interleukin-1β gene polymorphism is associated with joint erosions in rheumatoid arthritis. Eur Cytok Netw 1994; 5: 178A
   Google Scholar
• Tarlow J K, Blakemore A IF, Lennard A, Solari R, Hughes H N, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403–4
   PubMed Web of Science ®Google Scholar
• Pociot F, Nerup J. The IL-1 receptor antagonist. A new susceptibility marker in familial insulin-dependent diabetes (IDDM)? Lymphok Cytok Res 1993; 12: A201
   Google Scholar
• Blakemore A IF, Tarlow J K, Cork M J, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380–5
   PubMed Web of Science ®Google Scholar
• Mansfield J C, Holden H, Tarlow J K, Di Giovine F S, McDowell T L, Wilson A G, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637–42
   PubMed Web of Science ®Google Scholar
• Bioque G, Bouma G, Crusius J BA, Koutroubakis I, Kostense P J, Meuwissen S GM, et al. Evidence for genetic heterogeneity in IBD. I. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol 1995, In press
   Web of Science ®Google Scholar
• Danis V A, Millington M, Hyland V J, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303–10
   PubMed Web of Science ®Google Scholar
• Bioque G, Crusius J BA, Koutrobakis I, Bouma G, Kostense P J, Meuwissen S GM, et al. Allelic polymorphism in interleukin-l a and interleukin-1 receptor antagonist genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102, In press
   Web of Science ®Google Scholar
• Bouma G, Oudkerk Pool M, Scharenberg J GM, Kolkman J J, von Blomberg B ME, Scheper R J, et al. Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls. Scand J Gastroenterol 1995; 30: 1095–101
   PubMed Web of Science ®Google Scholar
• Bannai H, Asakura H, Sugimura K, Funakoshi K, Anezaki K, Sasakawa T, et al. TNF-alpha, beta and STNFR in ulcerative colitis. Gastroenterology 1994; 106: A649
   PubMedGoogle Scholar
• Spies T, Morton C C, Nedospasov S A, Fiers W, Pious D, Strominger JL. Genes for tumor necrosis factor alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 1986; 83: 8699
   PubMed Web of Science ®Google Scholar
• Baker E, Chen L Z, Smith C A, Callen D F, Goodwin R, Sutherland GR. Chromosomal location of the human tumor necrosis factor receptors genes. Cytogenet Cell Genet 1991; 57: 117–8
   PubMedGoogle Scholar
• Bendtzen K, Morling N, Fomsgaard A, Svenson M, Jakobsen B, Odum N, et al. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mono-nuclear cells activated by lipopolysaccharide. Scand J Immunol 1988; 28: 599–606
   PubMed Web of Science ®Google Scholar
• Jacob C O, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune ‘lupus’ nephritis. Nature 1988; 331: 3564
   Web of Science ®Google Scholar
• Messer G, Spengler U, Jung M C, Honold G, Blomer K, Pape G R, et al. Polymorphic structure of the tumor necrosis factor CnUF) locus: an Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173: 209–19
   PubMed Web of Science ®Google Scholar
• Pociot F, Briant L., Jongeneel C V, Mølvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224–31
   PubMed Web of Science ®Google Scholar
• Wilson A G, di Giovine F S, Blakemore A IF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353
   PubMedGoogle Scholar
• Wilson A G, de Vries N, Pociot F, di Giovine F S, van der Putte L BA, Duff GW. An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA Al, B8, and DR3 alleles. J Exp Med 1993; 177: 557–60
   PubMed Web of Science ®Google Scholar
• Wilson A G, Gordon C, di Giovine F S, de Vries N, van de Putte L BA, Emery P, et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994; 24: 191–5
   PubMed Web of Science ®Google Scholar
• McGuire W, Hill A VS, Allsopp C EM, Greenwood B M, Kwjatkowski D. Variation in the TNFα promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508–11
   PubMed Web of Science ®Google Scholar
• D'Alfonso S, Momigliano Richiardi P. A polymorphic variation in a putative regulation box of the TNFα promoter region. Immunogenetics 1994; 39: 150–4
   PubMed Web of Science ®Google Scholar
• Partanen J, Koskimies S. Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumor necrosis factor 8) gene. Scand J Immunol 1988; 28: 313–6
   PubMed Web of Science ®Google Scholar
• Webb G C, Chaplin DD. Genetic variability at the human tumor necrosis factor loci. J Immunol 1990; 145: 1278–85
   PubMed Web of Science ®Google Scholar
• Ferencik S, Lindemann M, Horsthemke B, Grosse-Wilde H. A new restriction fragment length polymorphism of the human TNF-β gene detected by AspHI digest. Eur J Immunogenet 1992; 19: 425–30
   PubMedGoogle Scholar
• Crusius J BA, Bing X, Mulder C JJ, Mearin M L, Penˆa AS. Relevance of haplotypes in the TNF region in celiac disease. Eur Cytok Netw 1994; 5: 168A
   Google Scholar
• Kaufman B A, White P S, Steinbrueck T, Donis-Keller H, Brodeur GM. Linkage mapping of the tumor necrosis factor receptor 2 (TNFR2) gene to 1p36.2 using the single-strand conformation polymorphism technique. Hum Genet 1994; 94: 418–22
   PubMed Web of Science ®Google Scholar
• Fiocchi C, Hilfiker M L, Youngman K R, Doerder N C, Finke JH. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 1984; 86: 73442
   Web of Science ®Google Scholar
• Kusugami K, Matsuura T, West G A, Youngman K R, Rachmilewitz D, Fiocchi C. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology 1991; 101: 1594–605
   PubMed Web of Science ®Google Scholar
• Miura M, Hiwatashi N. Cytokine production in inflammatory bowel disease. J Clin Lab Immunol 1985; 18: 81–6
   PubMedGoogle Scholar
• Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut 1992; 33: 933–7
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Juby L D, Heatley R V, Lobo A J, Bullimore D W, Axon A TR. Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut 1990; 31: 729–35
   Web of Science ®Google Scholar
• Brynskov J, Tvede N, Andersen C B, Vilien M. Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992; 33: 55–8
   PubMed Web of Science ®Google Scholar
• Sadlack B, Men H, Schorle H., Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253–61
   PubMed Web of Science ®Google Scholar
• Weldon M J, Maxwell JD. Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?. Gut 1994; 35: 867–71
   PubMed Web of Science ®Google Scholar
• Murray J C, Buetow K H, Smith M, Carlock L, Chakravarti A, Ferrell R F, et al. Pairwise linkage analysis of 11 loci on human chromosome 4. Am Hum Genet 1988; 42: 490–7
   PubMed Web of Science ®Google Scholar
• Epplen C, Frank G, Gomolka M, Nagy M, Nurnberg P, Epplen J. Dinucleotide repeat polymorphism in the IL2 and IL5RA genes. Hum Mol Genet 1994; 3: 679
   PubMedGoogle Scholar
• Ferrari S, Cannizzaro L A, Battini R, Huebner K, Baserga R. The gene encoding human vimentin is located on the short arm of chromosome 10. Am Hum Genet 1987; 41: 616–26
   PubMed Web of Science ®Google Scholar
• Gnarra J R, Otani H, Wang M G, McBride O W, Sharon M, Leonard WJ. Human interleukin 2 receptor β-chain gene: chromosomal localization and identification of 5′ regulatory sequences. Proc Natl Acad Sci USA 1990; 87: 3440–4
   PubMed Web of Science ®Google Scholar
• Puck J M, Deschenes S M, Porter J C, Dutra A S, Brown C J, Willard H F, et al. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 1993; 21099–104
   Web of Science ®Google Scholar
• Lobo A J, Evans S W, Jones S C, Banks R, Rathbone B J, Axon A TR, et al. Plasma interleukin-6 in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1992; 4: 367–72
   Web of Science ®Google Scholar
• Jones S C, Trejdosiewicz L K, Banks R E, Howdle P D, Axon A TR, Dixon M F, et al. Expression of interleukind by intestinal enterocytes. J Clin Pathol 1993; 46: 1097–100
   PubMed Web of Science ®Google Scholar
• Mahida Y R, Kurlac L, Gallagher A, Hawkey CJ. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991; 32: 1531–4
   PubMed Web of Science ®Google Scholar
• Woloski B M, Smith E M, Meyer W J, Fuller G M, Blalock JE. Corticotropin-releasing activity of monokines. Science 1985; 230: 1035–7
   PubMed Web of Science ®Google Scholar
• Bowcock A M, Kidd J R, Lathrop G M, Daneshvar L, May L T, Ray A, et al. The human ‘interferon-β2/hepatocyte stimulating factor/interleukin-6’ gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1988; 3: 8–16
   PubMedGoogle Scholar
• Kluck P M, Wiegant J, Jansen R P, Bolk M N, Raap A K, Willemze R, et al. The human interleukin-6 receptor alpha chain gene is localized on chromosome 1 band q21. Hum Genet 1993; 90: 5424
   Web of Science ®Google Scholar
• Silvennionen-Kassinen S, Pitkanen N, Ikaheimo I, Karvonen J, Tiilikainen A. The BglII and MspI RFLP-alleles of interleukin-6 gene in psoriasis vulgaris and nickel allergy patients. Scand J Immunol 1992; 36: A640
   Web of Science ®Google Scholar
• Mahida Y R, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ. Enhanced synthesis of neutrophil-activating pep-tide-1/interleukin-8 in active ulcerative colitis. Clin Sci 1992; 82: 27–5
   Web of Science ®Google Scholar
• Raab Y, Gerdin B, Ahlstedt S, Hallgren R. Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 1993; 34: 1203–6
   PubMed Web of Science ®Google Scholar
• Daig R, Andus T, Aschenbrenner E, Rath H, Falk W, Scholmaerich J, et al. Detection of interleukin-8-mRNA in mucosal mononuclear cells of patients with inflammatory bowel disease by in situ hybridization. Gastroenterology 1994; 106: A669
   Web of Science ®Google Scholar
• Izzo R S, Hadjiyane C, Mir R, Pellecchia C. In situ reverse transcription PCR of interleukin-8 mRNA in colonic mucosa from patients with active ulcerative colitis. Gastroenterology 1994; 106: A705
   Google Scholar
• Schaufelberger H D, Uhr M R, McGuckin C, Logan R PH, Misiewicz J J, Gordon Smith E C, et al. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukind receptors. Eur J Clin Invest 1994; 24: 656–63
   PubMed Web of Science ®Google Scholar
• Modi W S, Dean M, Seuanez H, Mukaida N, Matsushima K, O'Brien SJ. Monocyte-derived neutrophil chemotactic factor (MDNCFDG8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily. Hum Genet 1990; 84: 185–7
   PubMed Web of Science ®Google Scholar
• Fey M F, Tobler A. An interleukin-8 (IL8) cDNA clone identifies a frequent HindIII polymorphism. Hum Genet 1993; 91: 298
   PubMed Web of Science ®Google Scholar
• Kühn R, Lohler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263–74
   PubMed Web of Science ®Google Scholar
• Kim J M, Brannan C I, Copeland N G, Jenkins N A, Khan T A, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992; 148: 3618–23
   PubMed Web of Science ®Google Scholar
• Liu Y, Wei S H, Ho A S, de Waal Malefyt R, Moore KW. Expression cloning and characterization of a human IL-10 receptor. J Immunol 1994; 152: 1821–9
   PubMed Web of Science ®Google Scholar
• Pullman W E, Elsbury S, Kobayashi M, Hapel A J, Doe WF. Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 1992; 102: 529–37
   PubMed Web of Science ®Google Scholar
• Roe T F, Coates T D, Thomas D W, Miller J H, Gilsanz V. Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med 1992; 326: 1666–9
   PubMed Web of Science ®Google Scholar
• Gorgen I, Hartung T, Leist M, Niehorster M, Tiegs G, Uhlig S, et al. Granulocyte colony-stimulating factor treatment protects against LPS-induced toxicity via suppression of systemic tumor necrosis factor α. J Immunol 1992; 149: 918–21
   PubMed Web of Science ®Google Scholar
• Sherr C J, Rettenmier C W, Sacca R, Roussel M F, Look A T, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor CSF-1. Cell 1985; 41: 665–76
   PubMed Web of Science ®Google Scholar
• Mutchnick M G, Lee H H, Hollander D I, Haynes G D, Chua DC. Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin B4 levels in patients with inflammatory bowel disease. Clin Immunol Immunopharm 1988; 47: 84–92
   PubMedGoogle Scholar
• Fais S, Capobianchi M R, Pallone F, DiMarco P, Boirivant M, Danzani F, et al. Spontaneous release of interferon-gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vim response to interferon-gamma inducers. Gut 1991; 32: 403–7
   PubMed Web of Science ®Google Scholar
• Naylor S L, Sakaguchi A Y, Shows T B, Law M L, Goeddel D V, Gray PW. Human immune interferon gene is located on chromosome 12. J Exp Med 1983; 157: 1020–7
   PubMed Web of Science ®Google Scholar
• James S, Kwan W, Sneller M. T cells in inductive and effector components of the intestinal mucosal immune system of nonhuman primates differ in lymphokine mRNA expression, lymphokine utilisation and regulatory function. J Immunol 1990; 144: 1251–6
   PubMed Web of Science ®Google Scholar
• Küster W, Pascoe L, Pumnann J, Funk S, Majewski F. The genetics of Crohn's disease: complex segregation analysis of a family study with 265 patients with Crohn's disease and 5387 relatives. Am J Med Genet 1989; 32: 105–8
   PubMed Web of Science ®Google Scholar
• Orholm M, Iselius L, Sorensen T, Munkholm P, Langholz E, Binder V. Investigations of inheritance of chronic inflammatory bowel disease by complex segregation analysis. Br Med J 1993; 306: 20–4
   PubMedGoogle Scholar
• Kennedy G C, German M S, Rutter WJ. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genet 1995; 9293–8
   Web of Science ®Google Scholar
• Jacob CO. Genetic variability in tumor necrosis factor production: relevance to predisposition to autoimmune disease. Reg Immunol 1993; 4: 298–304
   Google Scholar
• Davies J L, Kawaguchi Y, Bennett S T, Copeman J B, Cordell H J, Pritchard L E, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 13W
   Web of Science ®Google Scholar
• Pociot F, Mølvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992; 22: 396–402
   PubMed Web of Science ®Google Scholar
• Borish L, Mascali J J, Klinnert M, Leppert M, Rosenwasser W. SSC polymorphisms in interleukin genes. Hum Mol Genet 1994; 3: 1710
   PubMed Web of Science ®Google Scholar
• Lloyd A, Modi W, Sprenger H, Cevario S, Oppenheim J, Kelvin D. Assignment of genes for interleukin-8 receptors (IL8R) A and B to human chromosome band 2q35. Cytogenet Cell Genet 1993; 63: 238–40
   PubMedGoogle Scholar
• Shaw M A, Atkinson S, Dockrell H, Hussain R, Lins-Lainson Z, Shaw J, et al. An RFLP map for 2q3-37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy. Ann Hum Genet 1993; 57: 251–71
   PubMed Web of Science ®Google Scholar
• Cottrell S, Bodmer W F, Markie D. TaqI RFLP for the IL2RA locus. Hum Mol Genet 1994; 3: 2085
   PubMed Web of Science ®Google Scholar